STRUCTURAL BIOLOGY & CHEMICAL EVIDENCEDataset v1.2 · Phase 6D · Comparative experimental recognition environments

Protein record

HDGFL2

Hepatoma-derived growth factor-related protein 2

Q7Z4V5 at UniProt
Homo sapiens671 amino acidsannotation supported
1annotated core in HDGFL2
86PDB entries with observed PWWP1 coordinates
4model records for PWWP1
5frozen v1.2 assay / association records for PWWP1

Canonical sequence · Source-mapped regions

Protein domain architecture

671 residues

PWWP annotation cores, other annotated regions, and deposited construct mappings share the canonical amino acid axis. The original Atlas PWWP intervals retain their source definitions.

PWWP annotation cores PWWP1 · 7–64 · UniProtKB reviewed feature · annotation core; not a certified complete folded domain or pocket Other source annotations No additional eligible domain features in the retrieved source. 1 168 336 503 671
PWWP annotation coreOther source annotationPredicted candidate, when present
0 additional source-supported regions · coordinates and evidence

UniProt feature coordinates accepted after exact canonical sequence identity check against the frozen Atlas. Source annotations can be inferred by sequence or curated from experiments; evidence codes remain attached. Other domain types link to their UniProt source because the Atlas records PWWP domains.

Deposited construct mapping

1 selected example

Colored segments map deposited polymer sequences to this canonical protein; dark segments have observed coordinates. Unmapped tags and engineered residues are not assigned canonical positions. These are not certified whole-fold boundaries.

8Z6Ochain A1–93
Mapped deposited segment 1–93 Observed canonical residues 3–93
Mapping and construct evidence

Deposited polymer length: 93 residues. Mapped sequence identity: 100.0%. no sequence difference detected by mapping; not proof of wild type.

PWWP1: 58 / 58 annotation-core Cα residues observed.

Frozen SIFTS aligned regions with construct-to-UniProt sequence comparison. Bars are mapped canonical segments; tags, insertions, and unmapped termini are not assigned canonical positions. PDB source.

One mapped example per native domain, preferring frozen experimental representatives; up to four distinct mapped intervals.

Validated isoform differences · 3 PWWP correspondence records

Only source-validated PWWP core correspondences from the frozen v1.2 isoform audit; other-domain architectures are not projected onto isoforms. Coordinates in the isoform column refer to the individual isoform sequence; deleted cores remain absent.

IsoformLengthPWWP coreSource-mapped positionsRetention / source edits
Q7Z4V5-2670PWWP17–64
58 / 58 mapped residues; span may contain gaps
complete
Q7Z4V5-3676PWWP17–64
58 / 58 mapped residues; span may contain gaps
complete
Q7Z4V5-4675PWWP17–64
58 / 58 mapped residues; span may contain gaps
complete
Viewing HDGFL2 PWWP1

Canonical annotation interval 7–64 · UniProtKB reviewed feature. annotation core; not a certified complete folded domain or pocket.

Alternative PWWP annotations and interval provenance
[
  {
    "end": 62,
    "identifier": "SM00293",
    "integrated_identifier": "IPR000313",
    "model": "SM00293",
    "name": "domain with conserved PWWP motif",
    "representative": false,
    "score": 3.1e-19,
    "source": "smart",
    "source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q7Z4V5/?page_size=200",
    "start": 5
  },
  {
    "end": 87,
    "identifier": "IPR000313",
    "integrated_identifier": null,
    "model": null,
    "name": "PWWP domain",
    "representative": false,
    "score": null,
    "source": "interpro",
    "source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q7Z4V5/?page_size=200",
    "start": 5
  },
  {
    "end": 88,
    "identifier": "cd20149",
    "integrated_identifier": null,
    "model": "cd20149",
    "name": "PWWP domain found in Hepatoma-derived growth factor-related protein 2 (HDGFL2)",
    "representative": false,
    "score": 1.87929e-60,
    "source": "cdd",
    "source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q7Z4V5/?page_size=200",
    "start": 5
  },
  {
    "end": 64,
    "identifier": "PS50812",
    "integrated_identifier": "IPR000313",
    "model": "PS50812",
    "name": "PWWP domain profile",
    "representative": false,
    "score": null,
    "source": "profile",
    "source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q7Z4V5/?page_size=200",
    "start": 7
  },
  {
    "end": 87,
    "identifier": "PF00855",
    "integrated_identifier": "IPR000313",
    "model": "PF00855",
    "name": "PWWP domain",
    "representative": false,
    "score": 5.8e-13,
    "source": "pfam",
    "source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q7Z4V5/?page_size=200",
    "start": 8
  }
]

PWWP1 · source-classified Phase 6A evidence

Ligands & Bioactivity

Explore all domain compounds →

75 chemical or preparation profiles · 7 domain-attributed assay / association observations. Counts refer to the curated snapshot.

73 profiles

Deposited research ligands

BPP2 observations · 2 research-ligand entriesvarenicline2 observations · 1 research-ligand entries(1R)-N-methyl-1-(pyridin-4-yl)propan-1-amine0 observations · 1 research-ligand entries(1S)-1-(1-phenyl-1H-1,2,3-triazol-4-yl)ethan-1-amine0 observations · 1 research-ligand entries(2,6-difluorophenyl)(pyrrolidin-1-yl)methanone0 observations · 1 research-ligand entries(2R)-1-(2-methyl-1H-imidazol-1-yl)propan-2-ol0 observations · 1 research-ligand entries(2R)-1-(cyclohexylamino)propan-2-ol0 observations · 1 research-ligand entries(2R)-2-ethyl-N,N-dimethylmorpholine-4-sulfonamide0 observations · 1 research-ligand entries(2R)-2-phenylpropane-1-sulfonamide0 observations · 1 research-ligand entries(2S)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)oxolane-2-carboxamide0 observations · 1 research-ligand entries(2S,5R)-4-[(5-chloro-1,2,3-thiadiazol-4-yl)methyl]-2,5-dimethylmorpholine0 observations · 1 research-ligand entries(3R)-N-methyl-1-(pyridazin-3-yl)piperidin-3-amine0 observations · 1 research-ligand entries(3S)-1-(methanesulfonyl)piperidine-3-carboxylic acid0 observations · 1 research-ligand entries(4-methylpiperazin-1-yl)[(2R)-oxolan-2-yl]methanone0 observations · 1 research-ligand entries(5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane0 observations · 1 research-ligand entries(5~{R})-7-pyrazin-2-yl-2-oxa-7-azaspiro[4.4]nonane0 observations · 1 research-ligand entries1-(1,4-diazepan-1-yl)ethan-1-one0 observations · 1 research-ligand entries1-(2-ethyl-1,3-thiazol-5-yl)-N-methylmethanamine0 observations · 1 research-ligand entries1-(diphenylmethyl)azetidin-3-ol0 observations · 1 research-ligand entries1-(ethanesulfonyl)piperidine-4-carboxylic acid0 observations · 1 research-ligand entries1-(methanesulfonyl)piperidin-4-ol0 observations · 1 research-ligand entries1-(propan-2-yl)-1H-imidazole-4-sulfonamide0 observations · 1 research-ligand entries1-[(1-methyl-1H-pyrazol-4-yl)methyl]piperazine0 observations · 1 research-ligand entries1-[(thiophen-3-yl)methyl]piperidin-4-ol0 observations · 1 research-ligand entries1-bromanyl-4-methylsulfonyl-benzene0 observations · 1 research-ligand entries1-cyclohexyl-N-methylmethanesulfonamide0 observations · 1 research-ligand entries2-(2,2-dimethylpyrrolidin-1-yl)ethan-1-amine0 observations · 1 research-ligand entries2-(4-bromanylpyrazol-1-yl)-~{N}-cyclopropyl-~{N}-methyl-ethanamide0 observations · 1 research-ligand entries2-(4-fluorophenoxy)-1-(pyrrolidin-1-yl)ethan-1-one0 observations · 1 research-ligand entries2-[(2S)-2-methylpiperidin-1-yl]ethan-1-amine0 observations · 1 research-ligand entries2-[4-(propan-2-yl)piperazin-1-yl]pyrimidine0 observations · 1 research-ligand entries2-[methyl(pyridin-2-yl)amino]ethan-1-ol0 observations · 1 research-ligand entries2-bromo-4-fluoro-N,N-dimethylbenzamide0 observations · 1 research-ligand entries2-chloro-N-methylbenzene-1-sulfonamide0 observations · 1 research-ligand entries2-methoxy-N-[(4-methylphenyl)methyl]acetamide0 observations · 1 research-ligand entries3-[(2S)-1-(methanesulfonyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole0 observations · 1 research-ligand entries3-cyclohexyl-1-(morpholin-4-yl)propan-1-one0 observations · 1 research-ligand entries4-[(5-chloro-1,2,3-thiadiazol-4-yl)methyl]morpholine0 observations · 1 research-ligand entries4-[[(5-bromanylpyridin-3-yl)methylamino]methyl]aniline0 observations · 1 research-ligand entries4-bromo-1H-pyrazole0 observations · 1 research-ligand entries4-IODOPYRAZOLE0 observations · 1 research-ligand entries5-bromanylpyrimidine0 observations · 1 research-ligand entries6-methyl-2-[(3-methyl-1,2-oxazol-5-yl)methyl]pyridazin-3(2H)-one0 observations · 1 research-ligand entries6-methyl-N-{[(3S)-pyrrolidin-3-yl]methyl}pyridin-2-amine0 observations · 1 research-ligand entries[(2R)-2-methylpiperidin-1-yl](4-methyl-1,3-thiazol-5-yl)methanone0 observations · 1 research-ligand entries[(3S)-1-(propan-2-yl)piperidin-3-yl]methanol0 observations · 1 research-ligand entries[3-[(5-bromanylpyridin-3-yl)methylamino]phenyl]methanol0 observations · 1 research-ligand entries[4-methyl-6-(piperidin-1-yl)pyrimidin-2-yl]methanol0 observations · 1 research-ligand entriesN,N,3,5-tetramethyl-1H-pyrazole-4-sulfonamide0 observations · 1 research-ligand entriesN,N-diethyl-2-methylbenzamide0 observations · 1 research-ligand entriesN,N-dimethylmorpholine-4-sulfonamide0 observations · 1 research-ligand entriesN,N-dimethylpiperazine-1-carboxamide0 observations · 1 research-ligand entriesN,N-dimethylpyridine-3-sulfonamide0 observations · 1 research-ligand entriesN-(2-fluorophenyl)ethanesulfonamide0 observations · 1 research-ligand entriesN-(4-acetylphenyl)-2-(pyrrolidin-1-yl)acetamide0 observations · 1 research-ligand entriesN-[(1S)-1-(pyridin-3-yl)ethyl]cyclopropanamine0 observations · 1 research-ligand entriesN-[(3R)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N-methyl-N'-propan-2-ylurea0 observations · 1 research-ligand entriesN-[(3S)-piperidin-3-yl]benzamide0 observations · 1 research-ligand entriesN-[(piperidin-4-yl)methyl]methanesulfonamide0 observations · 1 research-ligand entriesN-cycloheptyl-N-methylmethanesulfonamide0 observations · 1 research-ligand entriesN-ethyl-2-fluoro-4-(methylsulfonyl)aniline0 observations · 1 research-ligand entriesN-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)methanamine0 observations · 1 research-ligand entriesN-methyl-2-(methylsulfonyl)aniline0 observations · 1 research-ligand entriesN-methyl-3-oxo-N-(propan-2-yl)piperazine-1-sulfonamide0 observations · 1 research-ligand entriesN-methyl-N-(pyridin-3-yl)acetamide0 observations · 1 research-ligand entriesN-methyl-N-[2-oxo-2-(piperidin-1-yl)ethyl]methanesulfonamide0 observations · 1 research-ligand entriesN-{(1R)-1-[(4S)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}acetamide0 observations · 1 research-ligand entriesN-{[(4R)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}propanamide0 observations · 1 research-ligand entriesN~1~,N~1~,N~4~,N~4~-tetramethylpiperazine-1,4-dicarboxamide0 observations · 1 research-ligand entries~{N},~{N}-dimethyl-1~{H}-pyrazole-4-sulfonamide0 observations · 1 research-ligand entries~{N}-(3-azanyl-2-methyl-phenyl)propanamide0 observations · 1 research-ligand entries~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide0 observations · 1 research-ligand entries~{N}-methyl-1-pyridin-4-yl-methanamine0 observations · 1 research-ligand entries

0 profiles

Studied without research structure

No records in this category for the selected domain in the curated snapshot.

0 profiles

Experiment-specific controls

No records in this category for the selected domain in the curated snapshot.

5 other deposited components in this domain (not pharmacological ligands)

Buffers, ions, cryoprotectants and solvents remain recorded as deposited chemical components.

DIMETHYL SULFOXIDE · Other PDB component · not a studied ligand1,2-ETHANEDIOL · Other PDB component · not a studied ligandGLYCEROL · Other PDB component · not a studied ligandSULFATE ION · Other PDB component · not a studied ligand(4S)-2-METHYL-2,4-PENTANEDIOL · Other PDB component · not a studied ligand

Open this domain in Structural & Binding Landscape →

PWWP1 · Deposited coordinates

Experimental coverage and AlphaFold correspondence

86 entry / domain records

One representative chain per PDB entry and native domain. RMSD uses fixed UniProt correspondence and all common Cα atoms; it is reported only for ≥40 atoms and ≥80% core coverage. A value is descriptive, not a prediction benchmark.

PDBChainObserved core CαClassMethod / resolutionAF RMSD ÅReview
3EAEA58 / 58APOX-RAY DIFFRACTION
2.24 Å
1.14No classification flag
3QBYA58 / 58ComplexesX-RAY DIFFRACTION
1.95 Å
0.837Required
7HG0A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.58 Å
0.807No classification flag
7HG1A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.81 Å
0.754No classification flag
7HG2A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.7 Å
0.747No classification flag
7HG3A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.45 Å
0.788No classification flag
7HG4A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.57 Å
0.721No classification flag
7HG5A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.57 Å
0.746No classification flag
7HG6A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.52 Å
0.727No classification flag
7HG7A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.76 Å
0.765No classification flag
7HG8A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.67 Å
0.752No classification flag
7HG9A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.58 Å
0.717No classification flag
7HGAA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.57 Å
0.762No classification flag
7HGBA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.52 Å
0.77No classification flag
7HGCA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.51 Å
0.762No classification flag
7HGDA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.65 Å
0.768No classification flag
7HGEA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.77 Å
0.801No classification flag
7HGFA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.55 Å
0.747No classification flag
7HGGA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.61 Å
0.716No classification flag
7HGHA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.74 Å
0.776No classification flag
7HGIA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.71 Å
0.725No classification flag
7HGJA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.75 Å
0.777No classification flag
7HGKA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.59 Å
0.764No classification flag
7HGLA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.73 Å
0.718No classification flag
7HGMA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.61 Å
0.736No classification flag
7HGNA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.55 Å
0.79No classification flag
7HGOA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.44 Å
0.768No classification flag
7HGPA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.62 Å
0.738No classification flag
7HGQA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.76 Å
0.819No classification flag
7HGRA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.41 Å
0.76No classification flag
7HGSA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.51 Å
0.771No classification flag
7HGTA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.57 Å
0.759No classification flag
7HGUA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.67 Å
0.784No classification flag
7HGVA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.48 Å
0.728No classification flag
7HGWA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.59 Å
0.731No classification flag
7HGXA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.57 Å
0.777No classification flag
7HGYA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.61 Å
0.75No classification flag
7HGZA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.65 Å
0.762No classification flag
7HH0A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.6 Å
0.755No classification flag
7HH1A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.53 Å
0.764No classification flag
7HH2A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.78 Å
0.728No classification flag
7HH3A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.64 Å
0.764No classification flag
7HH4A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.49 Å
0.741No classification flag
7HH5A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.66 Å
0.754No classification flag
7HH6A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.71 Å
0.75No classification flag
7HH7A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.73 Å
0.758No classification flag
7HH8A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.81 Å
0.706No classification flag
7HH9A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.54 Å
0.732No classification flag
7HHAA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.8 Å
0.765No classification flag
7HHBA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.78 Å
0.755No classification flag
7HHCA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.59 Å
0.754No classification flag
7HHDA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.57 Å
0.721No classification flag
7HHEA58 / 58Co-CrystalsX-RAY DIFFRACTION
2.04 Å
0.765No classification flag
7HHFA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.86 Å
0.697No classification flag
7HHGA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.5 Å
0.785No classification flag
7HHHA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.69 Å
0.782No classification flag
7HHIA58 / 58Co-CrystalsX-RAY DIFFRACTION
2.11 Å
0.801No classification flag
7HHJA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.78 Å
0.766No classification flag
7HHKA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.94 Å
0.798No classification flag
7HHLA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.71 Å
0.758No classification flag
7HHMA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.78 Å
0.75No classification flag
7HHNA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.77 Å
0.745No classification flag
7HHOA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.76 Å
0.722No classification flag
7HHPA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.78 Å
0.726No classification flag
7HHQA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.6 Å
0.769No classification flag
7HHRA58 / 58Co-CrystalsX-RAY DIFFRACTION
2.03 Å
0.798No classification flag
8Z6CA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.93 Å
0.702No classification flag
8Z6OA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.55 Å
1.36No classification flag
9G91A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.78 Å
0.666No classification flag
9G94A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.73 Å
0.802No classification flag
9G96A58 / 58Co-CrystalsX-RAY DIFFRACTION
1.94 Å
0.678No classification flag
9GRSA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.66 Å
0.806No classification flag
9GRTA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.64 Å
0.778No classification flag
9GRUA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.7 Å
0.713No classification flag
9GRVA58 / 58Co-CrystalsX-RAY DIFFRACTION
1.55 Å
0.849No classification flag
9I7AA58 / 58APOX-RAY DIFFRACTION
1.05 Å
0.932No classification flag
9I7BA58 / 58APOX-RAY DIFFRACTION
1.41 Å
0.673No classification flag
9I7CA58 / 58APOX-RAY DIFFRACTION
1.55 Å
0.835No classification flag
9I7EA58 / 58APOX-RAY DIFFRACTION
1.58 Å
0.81No classification flag
9I7FC58 / 58APOX-RAY DIFFRACTION
2.08 Å
1.17No classification flag
9I7GA58 / 58APOX-RAY DIFFRACTION
1.93 Å
1.14No classification flag
9I7HA58 / 58APOX-RAY DIFFRACTION
1.54 Å
0.925No classification flag
9I7IA58 / 58APOX-RAY DIFFRACTION
1.4 Å
0.751No classification flag
9I7JA58 / 58APOX-RAY DIFFRACTION
1.8 Å
1.27No classification flag
3QJ6A56 / 58ComplexesX-RAY DIFFRACTION
2.3 Å
0.771Required
9I7DA53 / 58APOX-RAY DIFFRACTION
2.36 Å
0.412No classification flag

PWWP1 · Measured preparations

Frozen v1.2 assay records

Explore evidence links

This retained table is the original source projection. The Phase 5 Ligands & Bioactivity section above includes added observations and reviewed target context. Values remain attached to their assay, construct and preparation. A crystal structure does not transfer affinity to another construct or stereoisomer. Assay pages preserve field-level source-verification states where reviewed; unreviewed null fields remain uncurated.

Preparation / identityAssay and resultConstructEvidence and source
BPP
exact single CCD identity
NMR chemical-shift perturbation Kd
= 7.0 µM ± 5.0
direct binding affinity
1–93PMID:39031937
primary_publisher_selected_indexed_Results_and_Methods_passages; Figure S2 not independently retrieved

Intermediate-exchange NMR fit has large fitting error; ITC cross-validation reported, exact separate ITC number not extracted.

Assay conditions and interpretation

{"fit_model": "1:1 binding; global fit with shared Kd", "ligand_to_protein_molar_ratio_range": [0, 6], "protein_concentration_uM": 100, "protein_construct": "HDGFL2 1–93"}

Authors report intermediate-exchange limitations and additional ITC validation. This record preserves the NMR value and fitting error.

H4K20me3 peptide / trimethyllysine monomer
defined modified peptide sequence not monomer identity
Fluorescence polarization binding
Very weak; too weak to fit reliably
qualitative weak binding
UncuratedPMID:21720545
local_primary_full_text_XML_table_verified
Assay conditions and interpretation

{"sequence": "AKRHRK(me3)VLRDN"}

Solution binding cannot be quantified from this record; structural occupancy separately linked to 3QBY.

H4K20me3 peptide / trimethyllysine monomer
defined modified peptide sequence not monomer identity
X-ray structural association; no pharmacological activity assigned
No verified numeric value
structural occupancy association
UncuratedPMID:21720545
local_primary_full_text_XML; Tables 1-2, crystallization methods and ligand Results inspected

M3L has a polymer residue identity. 3QBY structural occupancy coexists with very weak unfittable solution affinity in Table 1.

Assay conditions and interpretation

{}

Chain H is an 11-residue H4K20me3 peptide AKRHR(M3L)VLRDN. M3L is a modified polymer monomer, not a free drug. The modeled subset must be distinguished from the full deposited peptide.

NbH10
named macromolecule no full sequence identity
SPR apparent Kd
= 81.2 nM ± 1.8
direct binding affinity
1–93PMID:42194065
local_primary_full_text_XML_table_and_methods_verified
Assay conditions and interpretation

{"protein_construct": "HDGFL2 1–93", "replicates": 3, "uncertainty_type": "SD"}

Apparent SPR affinity of a nanobody; not a small molecule or a solved nanobody–PWWP complex.

varenicline
exact single CCD identity
NMR chemical-shift perturbation Kd
= 250.0 µM ± 40.0
direct binding affinity
1–93PMID:39031937
primary_publisher_selected_indexed_Results_and_Methods_passages; Figure S2 not independently retrieved

Full assay buffer, temperature and incubation metadata not transcribed; null means uncurated, not absent.

Assay conditions and interpretation

{"fit_model": "1:1 binding; global fit with shared Kd", "ligand_to_protein_molar_ratio_range": [0, 6], "protein_concentration_uM": 100, "protein_construct": "HDGFL2 1–93"}

Converted from 0.25 ± 0.04 mM. Receptor pharmacology in other systems is not evidence of PWWP potency.

Scientific review queue

PWWP1 · Prediction evidence

Predicted models

4 model records

Domain retention uses independently reconstructed UniProt isoform edits. Local pLDDT is not experimental confirmation and does not establish interdomain orientation.

ModelOriginCore retentionCore mean pLDDTFull mean pLDDTCautions
AF-Q7Z4V5-F1:v6
Canonical
GDMcomplete88.859.9
AF-Q7Z4V5-2-F1:v6GDMcomplete88.759.7
AF-Q7Z4V5-3-F1:v6GDMcomplete88.860
AF-Q7Z4V5-4-F1:v6GDMcomplete88.859.9

PWWP1 · Structural correspondence

Human annotation-core comparisons

17 pairs

Structural alignment establishes a residue correspondence for these cropped cores. It does not establish equivalent ligand pockets, function or selectivity.

Domain pairAligned CαUS-align RMSD ÅTM score A / BView
ARID4A PWWP1 HDGFL2 PWWP1581.710.541 / 0.802Aligned core viewer
BRD1 PWWP1 HDGFL2 PWWP1582.480.56 / 0.766Aligned core viewer
BRPF1 PWWP1 HDGFL2 PWWP1581.840.59 / 0.812Aligned core viewer
BRPF3 PWWP1 HDGFL2 PWWP1581.770.585 / 0.799Aligned core viewer
DNMT3A PWWP1 HDGFL2 PWWP1581.220.861 / 0.873Aligned core viewer
DNMT3B PWWP1 HDGFL2 PWWP1581.190.863 / 0.876Aligned core viewer
HDGF PWWP1 HDGFL2 PWWP1572.050.747 / 0.747Aligned core viewer
HDGFL2 PWWP1 HDGFL3 PWWP1571.040.923 / 0.923Aligned core viewer
HDGFL2 PWWP1 MSH6 PWWP1562.130.761 / 0.713Aligned core viewer
HDGFL2 PWWP1 NSD2 PWWP1551.790.795 / 0.72Aligned core viewer
HDGFL2 PWWP1 NSD3 PWWP1561.960.791 / 0.727Aligned core viewer
HDGFL2 PWWP1 NSD3 PWWP2572.180.769 / 0.719Aligned core viewer
HDGFL2 PWWP1 PSIP1 PWWP1571.750.801 / 0.739Aligned core viewer
HDGFL2 PWWP1 PWWP2B PWWP1521.720.769 / 0.736Aligned core viewer
HDGFL2 PWWP1 PWWP3A PWWP1512.230.68 / 0.645Aligned core viewer
HDGFL2 PWWP1 ZMYND11 PWWP1512.080.687 / 0.747Aligned core viewer
HDGFL2 PWWP1 ZMYND8 PWWP1512.010.689 / 0.762Aligned core viewer